ABSTRACT
Relevant research in recent years has demonstrated that the atrial fibrillation occurrence rate is significantly higher in patients with cirrhosis. The most common indication for long-term anticoagulant therapy is chronic atrial fibrillation. The use of anticoagulant therapy greatly reduces the incidence rate of ischemic stroke. Patients with cirrhosis combined with atrial fibrillation have an elevated risk of bleeding and embolism during anticoagulant therapy due to cirrhotic coagulopathy. At the same time, the liver of such patients will go through varying levels of metabolism and elimination while consuming currently approved anticoagulant drugs, thereby increasing the complexity of anticoagulant therapy. This article summarizes the clinical studies on the risks and benefits of anticoagulant therapy in order to provide a reference for patients with cirrhosis combined with atrial fibrillation.
Subject(s)
Atrial Fibrillation , Stroke , Humans , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Atrial Fibrillation/epidemiology , Stroke/prevention & control , Stroke/drug therapy , Stroke/epidemiology , Anticoagulants/therapeutic use , Hemorrhage , Liver Cirrhosis/complications , Liver Cirrhosis/drug therapy , Risk FactorsABSTRACT
The ocean is the main source of thermal inertia in the climate system. Ocean heat uptake during recent decades has been quantified using ocean temperature measurements. However, these estimates all use the same imperfect ocean dataset and share additional uncertainty due to sparse coverage, especially before 2007. Here, we provide an independent estimate by using measurements of atmospheric oxygen (O2) and carbon dioxide (CO2) - levels of which increase as the ocean warms and releases gases - as a whole ocean thermometer. We show that the ocean gained 1.29 ± 0.79 × 1022 Joules of heat per year between 1991 and 2016, equivalent to a planetary energy imbalance of 0.80 ± 0.49 W watts per square metre of Earth's surface. We also find that the ocean-warming effect that led to the outgassing of O2 and CO2 can be isolated from the direct effects of anthropogenic emissions and CO2 sinks. Our result - which relies on high-precision O2 atmospheric measurements dating back to 1991 - leverages an integrative Earth system approach and provides much needed independent confirmation of heat uptake estimated from ocean data.
ABSTRACT
This Article has been retracted; see accompanying Retraction Note.
ABSTRACT
The ocean is the main source of thermal inertia in the climate system1. During recent decades, ocean heat uptake has been quantified by using hydrographic temperature measurements and data from the Argo float program, which expanded its coverage after 20072,3. However, these estimates all use the same imperfect ocean dataset and share additional uncertainties resulting from sparse coverage, especially before 20074,5. Here we provide an independent estimate by using measurements of atmospheric oxygen (O2) and carbon dioxide (CO2)-levels of which increase as the ocean warms and releases gases-as a whole-ocean thermometer. We show that the ocean gained 1.33 ± 0.20 × 1022 joules of heat per year between 1991 and 2016, equivalent to a planetary energy imbalance of 0.83 ± 0.11 watts per square metre of Earth's surface. We also find that the ocean-warming effect that led to the outgassing of O2 and CO2 can be isolated from the direct effects of anthropogenic emissions and CO2 sinks. Our result-which relies on high-precision O2 measurements dating back to 19916-suggests that ocean warming is at the high end of previous estimates, with implications for policy-relevant measurements of the Earth response to climate change, such as climate sensitivity to greenhouse gases7 and the thermal component of sea-level rise8.
ABSTRACT
BACKGROUND: Incontinence-associated dermatitis (IAD) is a specific type of irritant contact dermatitis with different severity levels. An internationally accepted instrument to assess the severity of IAD in adults, with established diagnostic accuracy, agreement and reliability, is needed to support clinical practice and research. OBJECTIVES: To design the Ghent Global IAD Categorization Tool (GLOBIAD) and evaluate its psychometric properties. METHODS: The design was based on expert consultation using a three-round Delphi procedure with 34 experts from 13 countries. The instrument was tested using IAD photographs, which reflected different severity levels, in a sample of 823 healthcare professionals from 30 countries. Measures for diagnostic accuracy (sensitivity and specificity), agreement, interrater reliability (multirater Fleiss kappa) and intrarater reliability (Cohen's kappa) were assessed. RESULTS: The GLOBIAD consists of two categories based on the presence of persistent redness (category 1) and skin loss (category 2), both of which are subdivided based on the presence of clinical signs of infection. The agreement for differentiating between category 1 and category 2 was 0·86 [95% confidence interval (CI) 0·86-0·87], with a sensitivity of 90% and a specificity of 84%. The overall agreement was 0·55 (95% CI 0·55-0·56). The Fleiss kappa for differentiating between category 1 and category 2 was 0·65 (95% CI 0·65-0·65). The overall Fleiss kappa was 0·41 (95% CI 0·41-0·41). The Cohen's kappa for differentiating between category 1 and category 2 was 0·76 (95% CI 0·75-0·77). The overall Cohen's kappa was 0·61 (95% CI 0·59-0·62). CONCLUSIONS: The development of the GLOBIAD is a major step towards a better systematic assessment of IAD in clinical practice and research worldwide. However, further validation is needed.
Subject(s)
Dermatitis, Irritant/etiology , Language , Severity of Illness Index , Urinary Incontinence/complications , Adult , Dermatitis, Irritant/diagnosis , Female , Humans , Internationality , Male , Observer Variation , Psychometrics , Reference Standards , Sensitivity and Specificity , Terminology as TopicABSTRACT
Wastewater in Shaoxing wastewater treatment plant (SWWTP) is composed of more than 90% dyeing and printing wastewater with high pH and sulfate. Through a combination process of anaerobic acidogenic [hydraulic retention time (HRT) of 15h], aerobic (HRT of 20h) and flocculation-precipitation, the total COD removal efficiency was up to 91%. But COD removal efficiency in anaerobic acidogenic unit was only 4%. As a comparison, the COD removal efficiency was up to 35% in the pilot-scale upflow anaerobic sludge bed (UASB) reactor (HRT of 15h). GC-MS analysis showed that the response abundance of these wastewater samples decreased with their removal of COD. A main component of the raw influent was long-chain n-alkanes. The final effluent of SWWTP had only four types of alkanes. After anaerobic unit at SWWTP, the mass percentage of total alkanes to total organic compounds was slightly decreased while its categories increased. But in the UASB, alkanes categories could be removed by 75%. Caffeine as a chemical marker could be detected only in the effluent of the aerobic process. Quantitative analysis was given. These results demonstrated that GC-MS analysis could provide an insight to the measurement of organic compounds removal.
Subject(s)
Coloring Agents/isolation & purification , Industrial Waste , Organic Chemicals/isolation & purification , Water Pollutants, Chemical/isolation & purification , Gas Chromatography-Mass SpectrometryABSTRACT
The paper was to evaluate anaerobic treatment efficiency of reducing toxic compounds by gas chromatography mass spectrometry (GC-MS) analysis combined with biological toxicity test during the treatment process of printing and dyeing wastewater. There had an obvious decrease trend in the response abundance of GC-MS chromatograms between raw influent and anaerobic effluents with the removal of COD. A main component of the raw effluent was long-chain n-alkanes. Alkanes in the expanded granular sludge bed (EGSB) categories could be reduced by 75%. EGSB had a better degradation performance on some complicated pollutants and toxicity. The most sensitive bioassay was Microtox bioassay.
Subject(s)
Anaerobiosis , Coloring Agents , Industrial Waste , Textile Industry , Water Pollutants, Chemical/toxicity , Gas Chromatography-Mass SpectrometrySubject(s)
Emergency Medical Services , Emergency Service, Hospital , Bed Occupancy/economics , Bed Occupancy/trends , Delivery of Health Care/economics , Delivery of Health Care/trends , Emergency Medical Services/economics , Emergency Medical Services/trends , Emergency Service, Hospital/economics , Emergency Service, Hospital/trends , Humans , Patient Admission/economics , Patient Admission/trendsABSTRACT
A previous investigation by our laboratory linked cellulose acetate degradation with adverse health effects in hemodialysis patients. To establish the accumulation of degradation products with time, a Monte Carlo model of degradation kinetics was developed. The model tracks changes in a population of molecules representative of the dialyzer membrane during the degradation process. The degradation calculation is a two step process: First, the model uses a random number to select an individual polymer molecule out of the population, and then a second random number is used to identify a site on the selected molecule for the degradation reaction to occur. After the reaction calculation, the resulting degraded molecules are redistributed into the population. The course of the reaction is determined by recalculating the molecular weight averages in the changing population as the calculations proceed. The model was validated using gel permeation chromatography molecular weight results and total acetyl content measurements on dialyzers stored up to 13.3 years after manufacture. It was found that the degradation reactions can be accurately modeled as random events and that the chain scissions and deacetylation events occur at constant rates. The shelf life of these devices was estimated using the model predictions and animal test results.
Subject(s)
Cellulose , Cellulose/analogs & derivatives , Kidneys, Artificial , Membranes, Artificial , Cellulose/adverse effects , Cellulose/chemistry , Drug Stability , Humans , In Vitro Techniques , Kidneys, Artificial/adverse effects , Models, Chemical , Molecular Weight , Monte Carlo Method , Safety , Time FactorsABSTRACT
A novel recombinant single-chain fragment variable (scFv) antibody against western equine encephalitis (WEE) virus has been previously constructed and partially characterized. The RS10B5huFc antibody was made by fusing an anti-WEE scFv to a human heavy-chain IgG1 constant region. The RS10B5huFc antibody was functional in binding to WEE virus in enzyme-linked immunosorbent assays (ELISAs), and the Fc domain of the antibody was capable of effector functions, such as binding to protein G and human complement. In this study, the RS10B5huFc antibody was further characterized by BIAcore analyses and was found to possess a binding affinity to a WEE virus epitope (K[D] = 9.14 x 10(-6) M), 4.5-fold lower than its parental mouse monoclonal antibody (MAb) 10B5 E7E2 (K[D] = 2 x 10(-6) M). No cross-reactivity was found between the RS10B5huFc antibody and three other alphaviruses (Sindbis virus [SIN], Venezuelan equine encephalitis [VEE] virus, and eastern equine encephalitis [EEE] virus). Pharmacokinetics studies showed that the RS10B5huFc antibody (free and encapsulated) was found to be retained in the lungs of mice for greater than 48 h when administered intranasally. In contrast, when administered intramuscularly to mice, the RS10B5huFc antibody was not detected in the lungs and only found in the liver and kidneys.
Subject(s)
Antibodies, Viral/administration & dosage , Encephalitis Virus, Western Equine/immunology , Immunoglobulin Fragments/administration & dosage , Immunoglobulin Variable Region/administration & dosage , Recombinant Fusion Proteins/administration & dosage , Administration, Intranasal , Alphavirus/immunology , Animals , Antibodies, Viral/metabolism , Antibodies, Viral/pharmacology , Antibody Specificity , Cross Reactions , Drug Compounding , Immunoglobulin Fragments/metabolism , Immunoglobulin Fragments/pharmacology , Immunoglobulin Variable Region/metabolism , Immunoglobulin Variable Region/pharmacology , Injections, Intramuscular , Liposomes , Mice , Mice, Inbred BALB C , Organ Specificity , Recombinant Fusion Proteins/pharmacokinetics , Tissue DistributionABSTRACT
Managed care companies contend there is still waste in the healthcare system that should be eliminated. Healthcare providers argue that further cuts will reduce quality. Which side is right? In order to answer this question it is necessary to determine the threshold implicit in the corollary question: How far can we go in reducing healthcare expense without diminishing quality? A new variability based methodology is proposed that has the potential to determine the threshold at which cost reduction will negatively impact quality. Illustrations of its specific application are provided.
Subject(s)
Managed Care Programs/economics , Managed Care Programs/standards , Quality of Health Care , Cost Control/methods , Cost-Benefit AnalysisABSTRACT
A repertoire of mouse monoclonal antibodies (MAbs) against western equine encephalitis virus (WEE) was constructed and characterized. Anti-WEE antibodies were expressed from hybridomas and purified by protein G chromatography. Each of the antibodies was functionally assessed by indirect enzyme-linked immunosorbent assays (ELISAs), Western blotting, and immunoprecipitations. All antibodies bound to WEE antigen in ELISAs, whereas only a subgroup of antibodies was found to be active in Western blotting and immunoprecipitations. A subset of antibodies was found to cross-react with other alphaviruses, such as Sindbis virus (SIN), Venezuelan equine encephalitis (VEE), and eastern equine encephalitis (EEE). Because many of the antibodies were highly reactive to WEE antigen in one or more of the assays, these antibodies are excellent candidates for immunodetection and immunotherapy studies.
Subject(s)
Antibodies, Monoclonal/immunology , Encephalitis Virus, Western Equine/immunology , Animals , Antigens, Viral/immunology , Blotting, Western , Cross Reactions , Encephalitis Virus, Eastern Equine/immunology , Encephalitis Virus, Venezuelan Equine/immunology , Enzyme-Linked Immunosorbent Assay , Hybridomas/chemistry , Immunoglobulin Isotypes/analysis , Mice , Mice, Inbred BALB C , Precipitin Tests , Sindbis Virus/immunologyABSTRACT
A novel recombinant single-chain fragment variable (scFv) antibody against Western equine encephalitis virus (WEE) was constructed and characterized. Using antibody phage display technology, a scFv was generated from the WEE specific hybridoma, 10B5 E7E2. The scFv was fused to a human heavy chain IgG1 constant region (CH1-CH3) and contained an intact 6 His tag and enterokinase recognition site (RS10B5huFc). The RS10B5huFc antibody was expressed in E. coli and purified by affinity chromatography as a 70-kDa protein. The RS10B5huFc antibody was functional in binding to WEE antigen in indirect enzyme-linked immunosorbent assays (ELISAs). Furthermore, the RS10B5huFc antibody was purified in proper conformation and formed multimers. The addition of the human heavy chain to the scFv replaced effector functions of the mouse antibody. The Fc domain was capable of binding to protein G and human complement. The above properties of the RS10B5huFc antibody make it an excellent candidate for immunodetection and immunotherapy studies.
Subject(s)
Antibodies, Viral/chemistry , Antibodies, Viral/genetics , Encephalitis Virus, Western Equine/immunology , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin Fc Fragments/genetics , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Recombinant Proteins/chemical synthesis , Amino Acid Sequence , Animals , Antibodies, Viral/isolation & purification , Antibodies, Viral/metabolism , Antigens, Viral/immunology , Antigens, Viral/metabolism , Binding Sites, Antibody , Cloning, Molecular , Humans , Hybridomas , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin Variable Region/metabolism , Mice , Molecular Sequence Data , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolismABSTRACT
Herpes simplex virus type 1 (HSV-1) infection alters the phosphorylation of the large subunit of RNA polymerase II (RNAP II), resulting in the depletion of the hypophosphorylated and hyperphosphorylated forms of this polypeptide (known as IIa and IIo, respectively) and induction of a novel, alternatively phosphorylated form (designated IIi). We previously showed that the HSV-1 immediate-early protein ICP22 is involved in this phenomenon, since induction of IIi and depletion of IIa are deficient in cells infected with 22/n199, an HSV-1 ICP22 nonsense mutant (S. A. Rice, M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer, J. Virol. 69:5550-5559, 1995). However, depletion of IIo still occurs in 22/n199-infected cells. This suggests either that another viral gene product affects the RNAP II large subunit or that the truncated ICP22 polypeptide encoded by 22/n199 retains residual activity which leads to IIo depletion. To distinguish between these possibilities, we engineered an HSV-1 ICP22 null mutant, d22-lacZ, and compared it to 22/n199. The two mutants are indistinguishable in their effects on the RNAP II large subunit, suggesting that an additional viral gene product is involved in altering RNAP II. Two candidates are UL13, a protein kinase which has been implicated in ICP22 phosphorylation, and the virion host shutoff (Vhs) factor, the expression of which is positively regulated by ICP22 and UL13. To test whether UL13 is involved, a UL13-deficient viral mutant, d13-lacZ, was engineered. This mutant was defective in IIi induction and IIa depletion, displaying a phenotype very similar to that of d22-lacZ. In contrast, a Vhs mutant had effects that were indistinguishable from wild-type HSV-1. Therefore, UL13 but not the Vhs function plays a role in modifying the RNAP II large subunit. To study the potential role of UL13 in viral transcription, we carried out nuclear run-on transcription analyses in infected human embryonic lung cells. Infections with either UL13 or ICP22 mutants led to significantly reduced amounts of viral genome transcription at late times after infection. Together, our results suggest that ICP22 and UL13 are involved in a common pathway that alters RNAP II phosphorylation and that in some cell lines this change promotes viral late transcription.
Subject(s)
Herpesvirus 1, Human/metabolism , Immediate-Early Proteins/metabolism , Protein Kinases/metabolism , RNA Polymerase II/metabolism , Viral Proteins , Animals , Cell Line , Chlorocebus aethiops , Cloning, Molecular , Genome, Viral , Herpesvirus 1, Human/genetics , Herpesvirus 1, Human/growth & development , Humans , Immediate-Early Proteins/genetics , Lac Operon , Mutagenesis , Phosphorylation , Protein Kinases/genetics , Transcription, Genetic , Vero Cells , Viral Regulatory and Accessory ProteinsABSTRACT
The DNA-dependent protein kinase (DNA-PK) is involved in several fundamental nuclear processes, including DNA double-strand break repair, V(D)J recombination, and transcription by RNA polymerases I and II. In this study, we show that infection of mammalian cells with herpes simplex virus type 1 attenuates DNA-PK activity by specifically depleting the p350/DNA-PKcs catalytic subunit. The half-life of the p350/DNA-PKcs protein decreases from greater than 24 h to less than 4 h following infection. The depletion of DNA-PK activity and p350/DNA-PKcs abundance is dependent on expression of the viral immediate-early protein ICP0. As ICP0 acts as a promoter-independent transactivator of gene expression, these data suggest that ICP0 may function by directly or indirectly targeting the p350/DNA-PKcs subunit of DNA-PK, thereby altering the inhibitory effects of DNA-PK on RNA polymerase II transcription.
Subject(s)
DNA-Binding Proteins , Herpesvirus 1, Human/metabolism , Immediate-Early Proteins/metabolism , Protein Serine-Threonine Kinases/antagonists & inhibitors , Trans-Activators/metabolism , Amino Acid Sequence , Binding Sites , DNA-Activated Protein Kinase , HeLa Cells , Herpesvirus 1, Human/genetics , Humans , Immediate-Early Proteins/genetics , Molecular Sequence Data , Nuclear Proteins , Tumor Cells, Cultured , Ubiquitin-Protein LigasesABSTRACT
Although death is a natural part of life, most people attempt to escape death by ignoring it. It is vital, however, for all health care personnel to understand the stages of the dying process and signs and symptoms of approaching death in order to provide support for patients and families.
Subject(s)
Attitude to Death , Death , Grief , Humans , Mental HealingABSTRACT
Infection of cells with herpes simplex virus type 1 (HSV-1) results in a rapid alteration of phosphorylation on the large subunit of cellular RNA polymerase II (RNAP II), most likely on its C-terminal domain (S. A. Rice, M. C. Long, V. Lam, C. A. Spencer, J. Virol. 68:988-1001, 1994). This phosphorylation modification generates a novel form of the large subunit which we have designed IIi. In this study, we examine roles that HSV-1 gene products play in this process. An HSV-1 mutant defective in the immediate-early transcriptional activator protein ICP4 is able to efficiently induce IIi. Viruses having mutations in the genes for the ICP0, ICP6, or ICP27 proteins are also competent for IIi formation. In contrast, 22/n199, an HSV-1 mutant which contains a nonsense mutation in the gene encoding the immediate-early protein ICP22, is significantly deficient in IIi induction. This effect is seen in Vero cells, where 22/n199 grows relatively efficiently, and in human embryonic lung (HEL) cells, where 22/n199 growth in more restricted. RNAP II is recruited into viral replication compartments in 22/n199-infected cells, indicating that altered phosphorylation of RNAP II is not a prerequisite for nuclear relocalization of RNAP II. In addition, we show by nuclear run-on transcription analysis that viral gene transcription is deficient in HEL cells infected with 22/n199. Viral late gene transcription does not occur efficiently, and antisense transcription throughout the genome is diminished compared with that of the wild-type HSV-1 infection. These transcriptional effects cannot be explained by differences in viral DNA replication, since 22/n199 replicates its DNA efficiently in HEL cells. Our results demonstrated that ICP22 is necessary for virus-induced aberrant phosphorylation of RNAP II and for normal patterns of viral gene transcription in certain cell lines.
Subject(s)
DNA-Binding Proteins/metabolism , Gene Expression Regulation, Viral , Herpesvirus 1, Human/physiology , Immediate-Early Proteins/metabolism , RNA Polymerase II/metabolism , Transcription, Genetic , Viral Proteins , Virus Replication , Animals , Blotting, Western , Cell Line , Cell Nucleus/metabolism , Chlorocebus aethiops , Fluorescent Antibody Technique , Genes, Viral , Herpesvirus 1, Human/genetics , Humans , Immediate-Early Proteins/analysis , Immediate-Early Proteins/biosynthesis , Kinetics , Lung , Mutagenesis , RNA Polymerase II/isolation & purification , Vero Cells , Viral Regulatory and Accessory ProteinsABSTRACT
To increase perioperative experience and knowledge, operating room staff members of a southeastern US veterans affairs hospital and the faculty of a nearby college of nursing baccalaureate program developed a perioperative nursing elective. The course included both classroom and clinical experiences. Benefits to students include the ability to transfer knowledge and skills to other clinical settings, increased understanding of the trauma of the surgical experience for the patient, and increased interest in a career in perioperative nursing.
Subject(s)
Curriculum , Education, Nursing, Baccalaureate/organization & administration , Operating Room Nursing/education , Evaluation Studies as Topic , Florida , Hospitals, Veterans , Humans , Interinstitutional Relations , Schools, NursingABSTRACT
During lytic infection, herpes simplex virus subverts the host cell RNA polymerase II transcription machinery to efficiently express its own genome while repressing the expression of most cellular genes. The mechanism by which RNA polymerase II is directed to the viral delayed-early and late genes is still unresolved. We report here that RNA polymerase II is preferentially localized to viral replication compartments early after infection with herpes simplex virus type 1. Concurrent with recruitment of RNA polymerase II into viral compartments is a rapid and aberrant phosphorylation of the large subunit carboxy-terminal domain (CTD). Aberrant phosphorylation of the CTD requires early viral gene expression but is not dependent on viral DNA replication or on the formation of viral replication compartments. Localization of RNA polymerase II and modifications to the CTD may be instrumental in favoring transcription of viral genes and repressing specific transcription of cellular genes.